12 completed, 2 unknown. 14 Phase 2, 3 Phase 1, 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 14 | Completed 12, Unknown 2 |
| Phase 1 | 3 | Completed 3 |
| Phase 3 | 2 | Completed 1, Unknown 1 |
Follow prucalopride: new trials by email Literature Review of prucalopride trials Research Report on prucalopride
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The Effect of Prucalopride on Gastric Emptying in Intensive Care Unit Patients Prucalopride, Metoclopramide - Enteral Feeding Intolerance | Phase 1 / Phase 2 | Completed | Ain Shams University | 70 | 2022-08-30 | 2024-04-12 |
| Preventing Gastric Glitch With Prucalopride and Buspirone: N-of-1 Clinical Trial Prucalopride, Buspirone, Placebo - Dyspepsia | Phase 1 / Phase 2 | Completed | Universidade de Passo Fundo | 1 | 2022-01-06 | 2022-05-17 |
| Prucalopride for Postoperative Ileus in Patients Undergoing Robot-assisted Laparoscopic Radical Cystectomy Prucalopride, Placebo - Postoperative Ileus, Bladder Cancer | Phase 2 | Unknown | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | 160 | 2021-09-01 | 2021-08-12 |
| The Effects of Prucalopride in Patients With Constipation Predominant Irritable Bowel Syndrome Prucalopride 2mg - Irritable Bowel Syndrome | Phase 2 / Phase 3 | Unknown | Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh | 160 | 2021-03-10 | 2021-10-22 |
| Treatment of Dysphagia and Ineffective Esophageal Motility With Prucalopride: A Pilot Study Prucalopride - Ineffective Esophageal Motility, Dysphagia | Phase 2 | Completed | University of Calgary | 28 | 2017-10-20 | 2020-03-25 |
| Phase 1/2a Trial of YH12852 in Healthy Subjects and Patients With Functional Constipation YH12852 IR 0.05mg, YH12852 IR 0.1mg, YH12852 IR 0.3mg - Functional Constipation | Phase 1 / Phase 2 | Completed | Yuhan Corporation | 120 | 2015-08-01 | 2016-10-31 |
| Prucalopride Versus Placebo in Gastroparesis Prucalopride, Placebo - Gastroparesis, Diabetes Mellitus | Phase 2 / Phase 3 | Completed | University of Calgary | 15 | 2014-03-01 | 2020-10-08 |
| Prucalopride for Postoperative Ileus in Patients Undergoing Gastrointestinal Surgery Prucalopride, Placebo - Postoperative Ileus | Phase 2 | Completed | Jinling Hospital, China | 110 | 2013-11-01 | 2016-09-30 |
| Evaluation of the Safety and Tolerability of Prucalopride in Constipated Elderly Subjects Living in a Nursing Facility Prucalopride, Placebo - Constipation | Phase 2 | Completed | Movetis | 100 | 1999-02-01 | 2008-05-29 |
| Prucalopride in Patients With Chronic Idiopathic Constipation prucalopride, placebo - Constipation | Phase 2 | Completed | Movetis | 87 | 1997-04-01 | 2008-05-29 |
| Trial to Evaluate the Efficacy and Safety of R093877 in Patients With Chronic Idiopathic Constipation prucalopride, 2 mg prucalopride, 4 mg prucalopride - Constipation | Phase 2 | Completed | Movetis | 313 | 1996-09-01 | 2008-05-29 |
| Efficacy and Safety Study of Prucalopride for the Treatment of Chronic Constipation Prucalopride, Placebo - Constipation | Phase 2 | Completed | Movetis | 253 | 1995-11-01 | 2008-05-29 |
| Efficacy and Safety Study of Prucalopride for the Treatment of Chronic Constipation Prucalopride, Placebo - Constipation | Phase 2 | Completed | Movetis | 174 | 1995-03-01 | 2008-05-29 |
| Effect of Prucalopride in Patients With Severe Chronic Idiopathic Constipation prucalopride, placebo - Chronic Constipation | Phase 2 | Completed | Movetis | 53 | 1994-12-01 | 2008-05-29 |
Constipation (6) · Deglutition Disorders (1) · Diabetes Mellitus (1) · Dyspepsia (1) · Gastrointestinal Diseases (1) · Gastroparesis (1) · Irritable Bowel Syndrome (1) · Urinary Bladder Neoplasms (1)
Movetis (6) · University of Calgary (2) · Ain Shams University (1) · Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh (1) · Jinling Hospital, China (1) · The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School (1) · Universidade de Passo Fundo (1) · Yuhan Corporation (1)
Canada (2) · Bangladesh (1) · Brazil (1) · China (1) · Egypt (1) · South Korea (1)
Christopher N Andrews, MD, MSc (1) · D O'Neill, MD (1) · Eman Elmokadem, PhD (1) · Fernando Fornari (1) · Georges Coremans, MD (1) · Howard Lee, MD, PhD (1) · Jianfeng Gong, MD (1) · Marc Van Outryve, MD (1) · Michael Kamm, MD (1) · Michelle Buresi, MD, PhD (1) · P. Van Eeghem, MD (1) · Prof.Dr. Anwarul Kabir, MD (1) · Trent Nichols, MD (1)
PMID 24732867, PMID 12144586, PMID 12743445, PMID 19751247, PMID 26880227, PMID 39584139